Clinuvel Pharmaceuticals revenue was $61.12M for the trailing 12 months ending Jun 30, 2025, with -2.1% growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, CUVL annual revenue was $61.1M, with 5.5% growth year-over-year.
CUVL past revenue growth
How has CUVL's revenue growth performed historically?
Clinuvel Pharmaceuticals (NASDAQ: CUVL) reported Q2 2025 revenue of N/A up N/A year over year. In the same quarter last year, Clinuvel Pharmaceuticals's revenue was N/A.
What was Clinuvel Pharmaceuticals's revenue in 2025?
Clinuvel Pharmaceuticals's annual revenue for the twelve months ending Jun 30, 2025 was $61.12 million, a 5.54% increase year over year.
How much does Clinuvel Pharmaceuticals make in a day?
Based on Clinuvel Pharmaceuticals annual revenue for the past two years, CUVL makes an average of $163,058.54 per day.
What was Clinuvel Pharmaceuticals's annual revenue growth in the past year?
As of Q3 2026, Clinuvel Pharmaceuticals's revenue has grown 5.54% year over year. Clinuvel Pharmaceuticals's revenue in the past year totaled $61.12 million.
How much does Clinuvel Pharmaceuticals make in a year?
Clinuvel Pharmaceuticals's revenue by year for the past two years is:
Clinuvel Pharmaceuticals's revenue for the twelve months ending Jun 30, 2025 was $61.12 million, a 5.54% increase year over year.
Clinuvel Pharmaceuticals's annual revenue for Jun 30, 2024 was $57.91 million, a 10.2% increase from 2023.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.